FranΓ§aisπ See the interactive version (live chart) β
For CareTrust REIT, we replayed every analyst price target of the past 12 months and measured the real outcome: 54% were profitable, average return +18% (54 calls). At 3 months: +5% average return (56% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Keybanc | 11 | 64% | +21% |
| Wells Fargo | 9 | 56% | +28% |
| Raymond James | 8 | 62% | +19% |
| RBC Capital | 7 | 71% | +24% |
| BMO Capital | 6 | 33% | +14% |
Is CareTrust REIT overvalued, and is it a good time to buy CareTrust REIT right now? If you're wondering, here's a recap to make up your own mind: CareTrust REIT's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | CareTrust REIT | Sector median (Real Estate) |
|---|---|---|
| P/E | 22.7 | 28.2 |
| Forward P/E | 19.3 | 32.9 |
| Net margin | 62% | 25% |
π CareTrust REIT trades below its sector median (22.7 vs 28.2) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : CareTrust REIT pays about $1.45/share/yr β 3.55% yield. what is this?
The analyst consensus on CareTrust REIT (CTRE) is "Buy" (19 bullish, 0 bearish calls over 12 months). This is not advice: historically, 54% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $43.00 (+19% vs $36.26), ranging from $41.00 to $45.00 (7 analysts).
Over 1 year, 54% of analyst targets on CareTrust REIT were profitable, for an average return of +18% (across 54 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $43.00 within 12 months, i.e. +19% vs the current price. The most bullish targets $45.00, the most cautious $41.00.
Note: analyst targets are 12-month (median $43.00, +19%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (54%), and the stock's past trajectory.
Its P/E is 22.7, forward P/E 19.3. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of CareTrust REIT β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.